Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial
PE Buszman, PP Buszman… - Cardiovascular …, 2016 - jacc.org
Objectives This study has reported 10-year clinical follow-up of patients enrolled in the
prospective, randomized LE MANS (Left Main Stenting) trial. Background The very long-term …
prospective, randomized LE MANS (Left Main Stenting) trial. Background The very long-term …
[HTML][HTML] Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in …
DM Charytan, M Desai, M Mathur, NM Stern… - Kidney international, 2016 - Elsevier
Coronary atherosclerotic disease is highly prevalent in chronic kidney disease (CKD).
Although revascularization improves outcomes, procedural risks are increased in CKD, and …
Although revascularization improves outcomes, procedural risks are increased in CKD, and …
Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry
PE Buszman, PP Buszman, RS Kiesz… - Journal of the American …, 2009 - jacc.org
Objectives: The aim of the study was to evaluate early and late outcomes after percutaneous
coronary intervention (PCI) of unprotected left main coronary artery disease (ULMCA) and to …
coronary intervention (PCI) of unprotected left main coronary artery disease (ULMCA) and to …
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing
Background The efficacy of paclitaxel-coated balloons (PCB) for restenosis prevention has
been demonstrated in humans. However, the mechanism of action for sustained drug …
been demonstrated in humans. However, the mechanism of action for sustained drug …
Extracellular matrix proteomics reveals interplay of aggrecan and aggrecanases in vascular remodeling of stented coronary arteries
G Suna, W Wojakowski, M Lynch… - Circulation, 2018 - Am Heart Assoc
Background: Extracellular matrix (ECM) remodeling contributes to in-stent restenosis and
thrombosis. Despite its important clinical implications, little is known about ECM changes …
thrombosis. Despite its important clinical implications, little is known about ECM changes …
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary …
Objectives: The aim of this study was to compare, in a large all-comer registry, the long-term
clinical outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents …
clinical outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents …
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of …
J Escaned, C Berry, B De Bruyne, A Shabbir… - EuroIntervention, 2023 - sfera.unife.it
The clinical value of fractional flow reserve and non-hyperaemic pressure ratios are well
established in determining an indication for percutaneous coronary intervention (PCI) in …
established in determining an indication for percutaneous coronary intervention (PCI) in …
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main …
Objectives: The aim of this study was to report the long-term clinical outcomes after
percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary …
percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary …
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first …
Objectives: This study sought to evaluate vascular drug uptake, distribution and response of
second-generation paclitaxel coated balloon (PCB)(Cotavance, MEDRAD Interventional …
second-generation paclitaxel coated balloon (PCB)(Cotavance, MEDRAD Interventional …
[HTML][HTML] BVS stent optimisation based on a parametric model with a multistage validation process
ŁA Mazurkiewicz, J Bukała, J Małachowski… - Materials & Design, 2021 - Elsevier
Developing new polymer-based bioresorbable vascular scaffolds (BVS) requires a new
structural geometry, as these polymer materials are characterised by substantially lower …
structural geometry, as these polymer materials are characterised by substantially lower …